Europe is lauded for the quality of its science, which might be a result of the great bet on both research and entrepreneurship. Thus, Europe is a rich biotech ecosystem, where we can found some Life Science Clusters. These clusters are characterized by a dynamic work environment where universities, hospitals, research institutions and companies work together in order to achieve the best possible results.
The leading Life Science Clusters in Europe (some of which are also world leaders) include:
This BioCluster accounts for 50% of Spanish Pharma industries
Research areas of excellence: pharmaceutical research, diagnosis, chemical and drug development
481 biotechnology, pharmaceutical and medical technology companies
80 research centers and 12 universities
About 22 000 people employed in the life sciences sector
Galicia is the 3rd most bio-entrepreneurial region in Spain
Research areas of excellence: food and agriculture, pharmaceutical, healthcare, nanobiotechnology, chemical, environment, engineering, cosmetics
250 biotech companies
3 500 jobs created in the industry
Cancer Bio-Santé Biotech Cluster (France)
Research areas of excellence: oncology
Cancer Bio-Santé connects players in innovation health academic laboratories, start-ups, SME’s, industrial groups and R&D funding, simulating and accelerating the creation of projects, products, innovation and value.
192 research projects approved (including 89 funded), up to the end of 2016
Stevenage Biotech Cluster (United Kingdom)
The latest edition of the Golden Triangle of biotech clusters
Located within the academic centers of London, Cambridge and Oxford
The Stevenage Biotech Cluster is one of the newest clusters in Europe, and is dominated as “The Bioscience Catalyst”
Research areas of excellence: therapeutics, cell and gene technologies
3 000 employees, 40+ companies
London-Cambridge-Oxford Bioscience Cluster (United Kingdom)
The strongest bioscience cluster in Europe, and is known as “The Golden Triangle” due to the association of the 3 clusters.
Research areas of excellence: London – stem cells, oncology, neurology, cardiovascular diseases, infection and drug delivery; Oxford – cancer, diabetes, immunology, inflammation; Cambridge – medtech, small molecules, antibody engineering, cancer, genomics.
49% of companies with R&D business model
390 life sciences companies, of which 89 are dedicated to biotechnology therapeutics and diagnosis, 137 to biotechnology R&D services, 67 are pharmaceutical companies, 78 work in the medical technology field and 19 in the food, agrotechnology or veterinary areas.
Ireland Cluster (Ireland)
Ireland can be view as a single cluster, and the main activities occur around the University of Cork, Dublin, Limerick and Galway
Research areas of excellence: medical technology, pharmaceuticals, diagnosis, therapeutics, biopharmaceutics
226 life science companies
50 000+ people employed, of whom 24 783 are researchers
Flanders Biotech Cluster (Belgium)
Research areas of excellence:: clinical research, gene research associated with disorders (cancer, coronaries or Alzheimer’s diseases) and cell therapy
147 active companies, of which 124 have R&D activities and 69 are in the field of healthcare biotechnology
Amsterdam Biotech Cluster (The Netherlands)
Research areas of excellence: regenerative medicine, inflammation, infection, oncology and neuroscience
The cluster is centered around 2 leading research universities (The University of Amsterdam and The Vrije University Amesterdam)
19 hospitals and over 100 support and service companies
291 health related biotechnology companies
Oslo Cancer Cluster (Norway)
Research areas of excellence: oncology, immunotherapy, vaccines
64 life science companies
Medicon Valley Cluster (Denmark and Sweden)
Research areas of excellence: clinical trials, personalised medicine, cancer, diabetes, neuroscience, drug delivery
7 Science parks, 28 Hospitals, 9 Universities, 12 internationally recognized research facilities
44 000 people employed in the life science sector, of which 5 000 are researchers
350 biotechnology and medtech companies with R&D and/or production
One of the largest of Germany’s 25 Biotech Clusters
Research areas of excellence: biopharmaceutical R&D – cell-based molecular medicine, cancer research, personalized and translational medicine
Supporting of around 40 R&D projects in the fields of biomarkers, tumor stem cells and drug development
80 companies in the medical biotechnology field
Vienna Cluster (Austria)
Research areas of excellence: medical biotechnology, anti-infectives, immunology, oncology, respiratory diseases, medical technology
25 research institutions and 5 Universities
378 biotech, pharma and medtech companies
About 14 289 people employed in Vienna’s research instituitions, of whom 7 744 are researchers
Munich Biotech (m4) Cluster (Germany)
Research areas of excellence: personalized medicine, production of antibiotics, biopharmaceuticals, therapeutics and diagnosis, bioinformatics, devices and reagents, preclinical services, DNA/protein analytics
2 leading universities - Ludwig-Maximilians-Universität and Technische Universität München
3 Max Planck Institutes – Biochemistry, Neurobiology and Psychiatry
2 university clinics and 60 other hospitals
377 life science companies including around 250 SMEs
BioValley Biotech Cluster (Switzerland, Germany and France)
Research areas of excellence: biopharmaceuticals, medical and surgical devices, imaging, robotics and stem cell transplants
14 Technology Parks, 10 Universities and Academic Research Centers
600+ pharmaceutical and medical technology companies
50 000 qualified employees, 15 000 scientists, 100 000 students
Do you know any other European Cluster/ Research center/ Biotech Company?
Tell us in the comments!
References:
Comments